# FDA Inspection 1122444 - Glenmark Pharmaceuticals Limited - February 21, 2020

Source: https://www.keypedia.com/records/fda_inspections/glenmark-pharmaceuticals-limited/7480abca-376a-48b0-8d6c-47a32ec70561
Source feed: FDA_Inspections

> FDA Inspection 1122444 for Glenmark Pharmaceuticals Limited on February 21, 2020. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1122444
- Company Name: Glenmark Pharmaceuticals Limited
- Inspection Date: 2020-02-21
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1298220 - 2025-11-28](https://www.keypedia.com/records/fda_inspections/glenmark-pharmaceuticals-limited/d6ea1e5d-9971-4606-b786-eb4e48130c63)
- [FDA Inspection 1252922 - 2024-09-20](https://www.keypedia.com/records/fda_inspections/glenmark-pharmaceuticals-limited/48017c94-fc20-45ae-9dcf-24c74165e434)
- [FDA Inspection 1252922 - 2024-09-20](https://www.keypedia.com/records/fda_inspections/glenmark-pharmaceuticals-limited/923d0216-0c9d-4f0e-907b-002451ceae5a)
- [FDA Inspection 1226884 - 2023-12-15](https://www.keypedia.com/records/fda_inspections/glenmark-pharmaceuticals-limited/e20d0e65-81e7-47c0-9a46-901c8174c2aa)
- [FDA Inspection 1065438 - 2018-08-17](https://www.keypedia.com/records/fda_inspections/glenmark-pharmaceuticals-limited/84e00ca0-c1d9-49f1-aa35-11332d0d7eec)

Company: https://www.keypedia.com/companies/glenmark-pharmaceuticals-limited/dacc6330-129c-4ce4-8c41-f71525daebe5

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c